Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19
Results of a monoclonal antibody (mAb) treatment program for high-risk Native American patients at a rural acute care facility on the Fort Apache Indian Reservation in eastern Arizona. Features demographics and statistics comparing 30-day outcomes among patients who did or did not receive mAb treatment between December 2020 and February 2021.
Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley
JAMA Network Open, 4(9)
American Indian or Alaska Native · Infectious diseases · Statistics and data · Arizona